{"id":1864,"date":"2023-07-17T13:19:28","date_gmt":"2023-07-17T17:19:28","guid":{"rendered":"https:\/\/www.arxresearch.com\/reports\/kol-fmv-rates-us-immunology\/"},"modified":"2023-07-19T09:43:19","modified_gmt":"2023-07-19T13:43:19","slug":"thought-leader-compensation-us-immunology","status":"publish","type":"product","link":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/","title":{"rendered":"Fair-Market Value Compensation Rates for Immunology KOLs &#8211; United States"},"content":{"rendered":"<p>Thought Leader Compensation US Immunology report presents fair-market value (FMV) hourly and half-day compensation rates for U.S. KOLs &#8211; Immunology, by percentiles, with averages, for four (4) levels of Thought Leader influences (rare, international, national and local). Thought Leader Compensation US Immunology.<\/p>\n<p>These defensible market-based rate data are built directly from industry compensation paid to Healthcare Practitioners (HCPs) and Thought Leaders (KOLs). All KOL FMV rates reports represent fair-market value established using our reliable methodology of collecting data from industry professionals involved in defining compensation levels for exchanges with KOLs worldwide.<\/p>\n<p>Establishing fair-market value compensation rates will:<\/p>\n<ul>\n<li>reduce the external perception of inappropriate inducement and limit regulatory and compliance risks.<\/li>\n<li>provide an independent reference for negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs).<\/li>\n<li>refine and support the development of fee schedules that are aligned with market conditions.<\/li>\n<li>competitively position the organization and support good business practices.<\/li>\n<\/ul>\n<p>The data included in each report are an aggregate of collected data and not individual rates. In no event, companies and individuals who provided the data are identified to protect their identity.<\/p>\n<p>Thought Leader Compensation US <a href=\"https:\/\/medical-dictionary.thefreedictionary.com\/immunology\">Immunology &#8211; definition<\/a>.<\/p>\n<p>Payments made to physicians and thought leaders have been under scrutiny for a few years and companies have been working to adjust their rates to level with industry standards.<br \/>\nNothing in this study constitutes financial or legal advice and we provide the contents of the study for information purposes only. This study may not be lent, resold, hired out or otherwise disposed of by way of trade in any form of binding or cover other than that in which it is published, without the prior written consent of Arx Research.<\/p>\n<p>INSIGHT<br \/>\nResearch\u00a0shows that less than 25% of pharmaceutical organizations begin working and involving Key Opinion Leaders during or before the clinical phase. Most \u2013 63% \u2013 wait during phases 2 and 3 to start exchanging with Thought Leaders. Read on here <a href=\"https:\/\/www.arxresearch.com\/kol-lifecycle-involvement\/\">KOL lifecycle involvement (arxresearch.com)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Thought Leader Compensation US Immunology presents hourly and half-day flat compensation rate cards for four (4) Thought Leader levels based on degree of influence. The data is presented by percentiles and outlines representative input directly from industry professionals involved in defining compensation levels for exchanges with KOLs.<\/p>\n<p>Number of pages: 8<br \/>\nFormat: Downloadable PDF<br \/>\nPublished: 2023<\/p>\n<p><strong>Price: Single-user $525 \/ Multi-users $990<\/strong><\/p>\n","protected":false},"featured_media":4693,"template":"","meta":[],"product_cat":[131],"product_tag":[155,133,132,134,153,135,142,140,141,138,137,268],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Thought Leader Compensation US Immunology (KOL-FMV)<\/title>\n<meta name=\"description\" content=\"This research report provides a study of FMV compensation rates for U.S. Thought Leaders (KOLs) in immunology (Thought Leader Compensation US Immunology).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thought Leader Compensation US Immunology (KOL-FMV)\" \/>\n<meta property=\"og:description\" content=\"This research report provides a study of FMV compensation rates for U.S. Thought Leaders (KOLs) in immunology (Thought Leader Compensation US Immunology).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/\" \/>\n<meta property=\"og:site_name\" content=\"Arx Research\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-19T13:43:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/712-USA-IMMUNO.png\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"375\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/\",\"url\":\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/\",\"name\":\"Thought Leader Compensation US Immunology (KOL-FMV)\",\"isPartOf\":{\"@id\":\"https:\/\/www.arxresearch.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/712-USA-IMMUNO.png\",\"datePublished\":\"2023-07-17T17:19:28+00:00\",\"dateModified\":\"2023-07-19T13:43:19+00:00\",\"description\":\"This research report provides a study of FMV compensation rates for U.S. Thought Leaders (KOLs) in immunology (Thought Leader Compensation US Immunology).\",\"breadcrumb\":{\"@id\":\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/#primaryimage\",\"url\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/712-USA-IMMUNO.png\",\"contentUrl\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/712-USA-IMMUNO.png\",\"width\":500,\"height\":375,\"caption\":\"Thought Leader Compensation US Immunology\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.arxresearch.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Reports\",\"item\":\"https:\/\/www.arxresearch.com\/reports\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Fair-Market Value Compensation Rates for Immunology KOLs &#8211; United States\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.arxresearch.com\/#website\",\"url\":\"https:\/\/www.arxresearch.com\/\",\"name\":\"Arx Research\",\"description\":\"Medical Affairs Benchmarking\",\"publisher\":{\"@id\":\"https:\/\/www.arxresearch.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.arxresearch.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.arxresearch.com\/#organization\",\"name\":\"Arx Research\",\"url\":\"https:\/\/www.arxresearch.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arxresearch.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/2015\/08\/arx-logo-left-web.png\",\"contentUrl\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/2015\/08\/arx-logo-left-web.png\",\"width\":217,\"height\":100,\"caption\":\"Arx Research\"},\"image\":{\"@id\":\"https:\/\/www.arxresearch.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/arx-research\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Thought Leader Compensation US Immunology (KOL-FMV)","description":"This research report provides a study of FMV compensation rates for U.S. Thought Leaders (KOLs) in immunology (Thought Leader Compensation US Immunology).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/","og_locale":"en_US","og_type":"article","og_title":"Thought Leader Compensation US Immunology (KOL-FMV)","og_description":"This research report provides a study of FMV compensation rates for U.S. Thought Leaders (KOLs) in immunology (Thought Leader Compensation US Immunology).","og_url":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/","og_site_name":"Arx Research","article_modified_time":"2023-07-19T13:43:19+00:00","og_image":[{"width":500,"height":375,"url":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/712-USA-IMMUNO.png","type":"image\/png"}],"twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/","url":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/","name":"Thought Leader Compensation US Immunology (KOL-FMV)","isPartOf":{"@id":"https:\/\/www.arxresearch.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/#primaryimage"},"image":{"@id":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/#primaryimage"},"thumbnailUrl":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/712-USA-IMMUNO.png","datePublished":"2023-07-17T17:19:28+00:00","dateModified":"2023-07-19T13:43:19+00:00","description":"This research report provides a study of FMV compensation rates for U.S. Thought Leaders (KOLs) in immunology (Thought Leader Compensation US Immunology).","breadcrumb":{"@id":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/#primaryimage","url":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/712-USA-IMMUNO.png","contentUrl":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/712-USA-IMMUNO.png","width":500,"height":375,"caption":"Thought Leader Compensation US Immunology"},{"@type":"BreadcrumbList","@id":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-us-immunology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.arxresearch.com\/"},{"@type":"ListItem","position":2,"name":"Reports","item":"https:\/\/www.arxresearch.com\/reports\/"},{"@type":"ListItem","position":3,"name":"Fair-Market Value Compensation Rates for Immunology KOLs &#8211; United States"}]},{"@type":"WebSite","@id":"https:\/\/www.arxresearch.com\/#website","url":"https:\/\/www.arxresearch.com\/","name":"Arx Research","description":"Medical Affairs Benchmarking","publisher":{"@id":"https:\/\/www.arxresearch.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.arxresearch.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.arxresearch.com\/#organization","name":"Arx Research","url":"https:\/\/www.arxresearch.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arxresearch.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/2015\/08\/arx-logo-left-web.png","contentUrl":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/2015\/08\/arx-logo-left-web.png","width":217,"height":100,"caption":"Arx Research"},"image":{"@id":"https:\/\/www.arxresearch.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/arx-research"]}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/product\/1864"}],"collection":[{"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/media\/4693"}],"wp:attachment":[{"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/media?parent=1864"}],"wp:term":[{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/product_cat?post=1864"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/product_tag?post=1864"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}